AzTrials
AzTrials

Mechanical VentilationNCT06452797

Prognostic Estimates Among ICU Clinicians

A study testing ProVent-14 score in people with Mechanical Ventilation, run by Rush University Medical Center at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

One challenge with decision making for mechanically ventilated is that their prognosis is often uncertain. The ProVent-14 score incorporates clinical variables measured on the 14th day of mechanical ventilation to predict risk of death in one year. The ProVent-14 is easy to calculate has been externally validated. Read more about this study

Who is it for?
Any age
Conditions the study is for
Mechanical Ventilation
What is being tested?
ProVent-14 score
Could I receive a placebo?
No, everyone receives an active treatment
How many people
238 participants
Where
3 sitesUnited States
Study dates
18 Jun 2024to 15 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • ICU day-shift attending physician, fellow physician, advanced practice provider, or nurse
  • Caring directly for a patient who requires invasive mechanical ventilation, 14-16 days after initial intubation, not actively transitioning to comfort-focused care and not with a neuromuscular disease (i.e. ALS) as a cause of respiratory failure.

Who cannot join

  • None

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Jared Greenberg, MD contact

312-942-6744

jared_greenberg@rush.edu

United States3 sites, 2 recruiting
  • University of North Carolina

    Chapel Hill, North Carolina, 27599

    David Y Hwang, MD, 919-966-8178, david_hwang@med.unc.edu

    David Y Hwang

    Recruiting
  • Rush University Medical Center

    Chicago, Illinois, 60612

    Jared A Greenberg, MD, 312-942-6744, jared_greenberg@rush.edu

    Recruiting
  • Rush Oak Park Hospital

    Oak Park, Illinois, 60304

    Active, not recruiting

Other trials in United States

About this study

Official title: Prognostic Estimates Among ICU Clinicians Caring for Patients Requiring Prolonged Mechanical Ventilation

One challenge with decision making for mechanically ventilated is that their prognosis is often uncertain. The ProVent-14 score incorporates clinical variables measured on the 14th day of mechanical ventilation to predict risk of death in one year. The ProVent-14 is easy to calculate has been externally validated. However, it is unclear how often clinicians use the ProVent-14 score to predict long-term outcomes for patients requiring 14 days of mechanical ventilation or if it helps clinicians make more accurate predictions. The purpose of this study is to determine whether ICU clinicians who receive a patient's ProVent-14 score make more accurate predictions for mortality at one year than ICU clinicians who do not.

Being tested
ProVent-14 score

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ProVent-14 scoreBehavioural

    A score to estimate one-year mortality for patients requiring at least 14 days of mechanical ventilation

Study groups in NCT06452797
Study groupRoleWhat they receive
Usual Prognostic ApproachNo interventionParticipants will make form a prognosis using their usual approach
ProVent-14 Guided Prognostic ApproachExperimentalParticipants will be asked to form a prognosis after being provided the patient's ProVent-14 score and its meaning
Receives: Behavioral: ProVent-14 score

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy of one-year mortality rate predictions

    Associations between participant predictions (0-100% risk of death) and patient outcomes (death or not) will be determined using logistic regression. Accuracy will be determined by Area Under the Receiver Operating Characteristic (AUROC) analysis.

    Measured: One-year after participant enrollment

Secondary outcomes (4)
  1. Confidence in prediction

    1-10 scale, 10 being most confident

    Measured: Upon enrollment

  2. Comfort communicating prognosis to patient/surrogate

    1-10 scale, 10 being most comfortable

    Measured: Upon enrollment

  3. Recommendation to transition to comfort-focused care

    Yes or No

    Measured: Upon enrollment

  4. Accuracy of timing of patient death

    Participants who predict the patient has a <50% chance of survival will be asked to predict the month the patient will pass away

    Measured: One-year after participant enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2024
  2. Study start18 Jun 2024
  3. Primary completion15 Jun 2027 (estimated)
  4. Study completion15 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
238 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06452797
Sponsor's protocol ID
24030801
Status last verified
Sep 2026
First submitted
5 Jun 2024
Last updated
28 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: to be determined

Publications

  • Cox CE, White DB, Hough CL, Jones DM, Kahn JM, Olsen MK, Lewis CL, Hanson LC, Carson SS. Effects of a Personalized Web-Based Decision Aid for Surrogate Decision Makers of Patients With Prolonged Mechanical Ventilation: A Randomized Clinical Trial. Ann Intern Med. 2019 Mar 5;170(5):285-297. doi: 10.7326/M18-2335. Epub 2019 Jan 29.

    PubMed 30690645
  • Detsky ME, Harhay MO, Bayard DF, Delman AM, Buehler AE, Kent SA, Ciuffetelli IV, Cooney E, Gabler NB, Ratcliffe SJ, Mikkelsen ME, Halpern SD. Discriminative Accuracy of Physician and Nurse Predictions for Survival and Functional Outcomes 6 Months After an ICU Admission. JAMA. 2017 Jun 6;317(21):2187-2195. doi: 10.1001/jama.2017.4078.

    PubMed 28528347
  • Hough CL, Caldwell ES, Cox CE, Douglas IS, Kahn JM, White DB, Seeley EJ, Bangdiwala SI, Rubenfeld GD, Angus DC, Carson SS; ProVent Investigators and the National Heart Lung and Blood Institute's Acute Respiratory Distress Syndrome Network. Development and Validation of a Mortality Prediction Model for Patients Receiving 14 Days of Mechanical Ventilation. Crit Care Med. 2015 Nov;43(11):2339-45. doi: 10.1097/CCM.0000000000001205.

    PubMed 26247337
  • Buehler AE, Ciuffetelli IV, Delman AM, Kent SA, Bayard DF, Cooney E, Halpern SD, Detsky ME. Contributors to Intensive Care Unit Clinicians' Predictions of Patient Outcomes: A Qualitative Analysis. Am J Crit Care. 2018 Nov;27(6):445-453. doi: 10.4037/ajcc2018100.

    PubMed 30385535

Questions about this trial

What is this clinical trial studying?

A study testing ProVent-14 score in people with Mechanical Ventilation, run by Rush University Medical Center at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jared Greenberg, MD (312-942-6744, jared_greenberg@rush.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy of one-year mortality rate predictions (time frame: One-year after participant enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06452797, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Prognostic Estimates Among ICU Clinicians | AzTrials